▶ 調査レポート

血液透析濃縮物のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Haemodialysis Concentrates Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。血液透析濃縮物のグローバル市場インサイト・予測(~2028年) / Global Haemodialysis Concentrates Market Insights, Forecast to 2028 / QY2207E09499資料のイメージです。• レポートコード:QY2207E09499
• 出版社/出版日:QYResearch / 2022年7月
• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,102,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の血液透析濃縮物の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に血液透析濃縮物の世界市場のxxx%を占める「重炭酸塩濃縮物」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「透析センター」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の血液透析濃縮物の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの血液透析濃縮物市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの血液透析濃縮物市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

血液透析濃縮物のグローバル主要メーカーには、Rockwell Medical、Nipro、MEDIVATORS、Dialysis Medical Solutions、Fresenius Medical Care、Baxter、B. Braun、Renacon Pharma、Surni Group、Weigao Group、BIOLIGHT、Taishikangなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

血液透析濃縮物市場は、種類と用途によって区分されます。世界の血液透析濃縮物市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
重炭酸塩濃縮物、酸濃縮物

【用途別セグメント】
透析センター、在宅透析、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 血液透析濃縮物製品概要
- 種類別市場(重炭酸塩濃縮物、酸濃縮物)
- 用途別市場(透析センター、在宅透析、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の血液透析濃縮物販売量予測2017-2028
- 世界の血液透析濃縮物売上予測2017-2028
- 血液透析濃縮物の地域別販売量
- 血液透析濃縮物の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別血液透析濃縮物販売量
- 主要メーカー別血液透析濃縮物売上
- 主要メーカー別血液透析濃縮物価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(重炭酸塩濃縮物、酸濃縮物)
- 血液透析濃縮物の種類別販売量
- 血液透析濃縮物の種類別売上
- 血液透析濃縮物の種類別価格
・用途別市場規模(透析センター、在宅透析、その他)
- 血液透析濃縮物の用途別販売量
- 血液透析濃縮物の用途別売上
- 血液透析濃縮物の用途別価格
・北米市場
- 北米の血液透析濃縮物市場規模(種類別、用途別)
- 主要国別の血液透析濃縮物市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの血液透析濃縮物市場規模(種類別、用途別)
- 主要国別の血液透析濃縮物市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の血液透析濃縮物市場規模(種類別、用途別)
- 主要国別の血液透析濃縮物市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の血液透析濃縮物市場規模(種類別、用途別)
- 主要国別の血液透析濃縮物市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの血液透析濃縮物市場規模(種類別、用途別)
- 主要国別の血液透析濃縮物市場規模(トルコ、サウジアラビア)
・企業情報
Rockwell Medical、Nipro、MEDIVATORS、Dialysis Medical Solutions、Fresenius Medical Care、Baxter、B. Braun、Renacon Pharma、Surni Group、Weigao Group、BIOLIGHT、Taishikang
・産業チェーン及び販売チャネル分析
- 血液透析濃縮物の産業チェーン分析
- 血液透析濃縮物の原材料
- 血液透析濃縮物の生産プロセス
- 血液透析濃縮物の販売及びマーケティング
- 血液透析濃縮物の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 血液透析濃縮物の産業動向
- 血液透析濃縮物のマーケットドライバー
- 血液透析濃縮物の課題
- 血液透析濃縮物の阻害要因
・主な調査結果

Market Analysis and Insights: Global Haemodialysis Concentrates Market
Due to the COVID-19 pandemic, the global Haemodialysis Concentrates market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Bicarbonate Concentrates accounting for % of the Haemodialysis Concentrates global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Dialysis Center segment is altered to an % CAGR throughout this forecast period.
China Haemodialysis Concentrates market size is valued at US$ million in 2021, while the US and Europe Haemodialysis Concentrates are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Haemodialysis Concentrates landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Haemodialysis Concentrates include Rockwell Medical, Nipro, MEDIVATORS, Dialysis Medical Solutions, Fresenius Medical Care, Baxter, B. Braun, Renacon Pharma and Surni Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Haemodialysis Concentrates Scope and Segment
Haemodialysis Concentrates market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Haemodialysis Concentrates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bicarbonate Concentrates
Acid Concentrates
Segment by Application
Dialysis Center
Home Dialysis
Others
By Company
Rockwell Medical
Nipro
MEDIVATORS
Dialysis Medical Solutions
Fresenius Medical Care
Baxter
B. Braun
Renacon Pharma
Surni Group
Weigao Group
BIOLIGHT
Taishikang
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Haemodialysis Concentrates Product Introduction
1.2 Market by Type
1.2.1 Global Haemodialysis Concentrates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bicarbonate Concentrates
1.2.3 Acid Concentrates
1.3 Market by Application
1.3.1 Global Haemodialysis Concentrates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dialysis Center
1.3.3 Home Dialysis
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Haemodialysis Concentrates Sales Estimates and Forecasts 2017-2028
2.2 Global Haemodialysis Concentrates Revenue Estimates and Forecasts 2017-2028
2.3 Global Haemodialysis Concentrates Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Haemodialysis Concentrates Sales by Region
2.4.1 Global Haemodialysis Concentrates Sales by Region (2017-2022)
2.4.2 Global Sales Haemodialysis Concentrates by Region (2023-2028)
2.5 Global Haemodialysis Concentrates Revenue by Region
2.5.1 Global Haemodialysis Concentrates Revenue by Region (2017-2022)
2.5.2 Global Haemodialysis Concentrates Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Haemodialysis Concentrates Sales by Manufacturers
3.1.1 Global Top Haemodialysis Concentrates Manufacturers by Sales (2017-2022)
3.1.2 Global Haemodialysis Concentrates Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Haemodialysis Concentrates in 2021
3.2 Global Haemodialysis Concentrates Revenue by Manufacturers
3.2.1 Global Haemodialysis Concentrates Revenue by Manufacturers (2017-2022)
3.2.2 Global Haemodialysis Concentrates Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Haemodialysis Concentrates Revenue in 2021
3.3 Global Haemodialysis Concentrates Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Haemodialysis Concentrates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Haemodialysis Concentrates Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Haemodialysis Concentrates Sales by Type
4.1.1 Global Haemodialysis Concentrates Historical Sales by Type (2017-2022)
4.1.2 Global Haemodialysis Concentrates Forecasted Sales by Type (2023-2028)
4.1.3 Global Haemodialysis Concentrates Sales Market Share by Type (2017-2028)
4.2 Global Haemodialysis Concentrates Revenue by Type
4.2.1 Global Haemodialysis Concentrates Historical Revenue by Type (2017-2022)
4.2.2 Global Haemodialysis Concentrates Forecasted Revenue by Type (2023-2028)
4.2.3 Global Haemodialysis Concentrates Revenue Market Share by Type (2017-2028)
4.3 Global Haemodialysis Concentrates Price by Type
4.3.1 Global Haemodialysis Concentrates Price by Type (2017-2022)
4.3.2 Global Haemodialysis Concentrates Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Haemodialysis Concentrates Sales by Application
5.1.1 Global Haemodialysis Concentrates Historical Sales by Application (2017-2022)
5.1.2 Global Haemodialysis Concentrates Forecasted Sales by Application (2023-2028)
5.1.3 Global Haemodialysis Concentrates Sales Market Share by Application (2017-2028)
5.2 Global Haemodialysis Concentrates Revenue by Application
5.2.1 Global Haemodialysis Concentrates Historical Revenue by Application (2017-2022)
5.2.2 Global Haemodialysis Concentrates Forecasted Revenue by Application (2023-2028)
5.2.3 Global Haemodialysis Concentrates Revenue Market Share by Application (2017-2028)
5.3 Global Haemodialysis Concentrates Price by Application
5.3.1 Global Haemodialysis Concentrates Price by Application (2017-2022)
5.3.2 Global Haemodialysis Concentrates Price Forecast by Application (2023-2028)
6 North America
6.1 North America Haemodialysis Concentrates Market Size by Type
6.1.1 North America Haemodialysis Concentrates Sales by Type (2017-2028)
6.1.2 North America Haemodialysis Concentrates Revenue by Type (2017-2028)
6.2 North America Haemodialysis Concentrates Market Size by Application
6.2.1 North America Haemodialysis Concentrates Sales by Application (2017-2028)
6.2.2 North America Haemodialysis Concentrates Revenue by Application (2017-2028)
6.3 North America Haemodialysis Concentrates Market Size by Country
6.3.1 North America Haemodialysis Concentrates Sales by Country (2017-2028)
6.3.2 North America Haemodialysis Concentrates Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Haemodialysis Concentrates Market Size by Type
7.1.1 Europe Haemodialysis Concentrates Sales by Type (2017-2028)
7.1.2 Europe Haemodialysis Concentrates Revenue by Type (2017-2028)
7.2 Europe Haemodialysis Concentrates Market Size by Application
7.2.1 Europe Haemodialysis Concentrates Sales by Application (2017-2028)
7.2.2 Europe Haemodialysis Concentrates Revenue by Application (2017-2028)
7.3 Europe Haemodialysis Concentrates Market Size by Country
7.3.1 Europe Haemodialysis Concentrates Sales by Country (2017-2028)
7.3.2 Europe Haemodialysis Concentrates Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Haemodialysis Concentrates Market Size by Type
8.1.1 Asia Pacific Haemodialysis Concentrates Sales by Type (2017-2028)
8.1.2 Asia Pacific Haemodialysis Concentrates Revenue by Type (2017-2028)
8.2 Asia Pacific Haemodialysis Concentrates Market Size by Application
8.2.1 Asia Pacific Haemodialysis Concentrates Sales by Application (2017-2028)
8.2.2 Asia Pacific Haemodialysis Concentrates Revenue by Application (2017-2028)
8.3 Asia Pacific Haemodialysis Concentrates Market Size by Region
8.3.1 Asia Pacific Haemodialysis Concentrates Sales by Region (2017-2028)
8.3.2 Asia Pacific Haemodialysis Concentrates Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Haemodialysis Concentrates Market Size by Type
9.1.1 Latin America Haemodialysis Concentrates Sales by Type (2017-2028)
9.1.2 Latin America Haemodialysis Concentrates Revenue by Type (2017-2028)
9.2 Latin America Haemodialysis Concentrates Market Size by Application
9.2.1 Latin America Haemodialysis Concentrates Sales by Application (2017-2028)
9.2.2 Latin America Haemodialysis Concentrates Revenue by Application (2017-2028)
9.3 Latin America Haemodialysis Concentrates Market Size by Country
9.3.1 Latin America Haemodialysis Concentrates Sales by Country (2017-2028)
9.3.2 Latin America Haemodialysis Concentrates Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Haemodialysis Concentrates Market Size by Type
10.1.1 Middle East and Africa Haemodialysis Concentrates Sales by Type (2017-2028)
10.1.2 Middle East and Africa Haemodialysis Concentrates Revenue by Type (2017-2028)
10.2 Middle East and Africa Haemodialysis Concentrates Market Size by Application
10.2.1 Middle East and Africa Haemodialysis Concentrates Sales by Application (2017-2028)
10.2.2 Middle East and Africa Haemodialysis Concentrates Revenue by Application (2017-2028)
10.3 Middle East and Africa Haemodialysis Concentrates Market Size by Country
10.3.1 Middle East and Africa Haemodialysis Concentrates Sales by Country (2017-2028)
10.3.2 Middle East and Africa Haemodialysis Concentrates Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Rockwell Medical
11.1.1 Rockwell Medical Corporation Information
11.1.2 Rockwell Medical Overview
11.1.3 Rockwell Medical Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Rockwell Medical Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Rockwell Medical Recent Developments
11.2 Nipro
11.2.1 Nipro Corporation Information
11.2.2 Nipro Overview
11.2.3 Nipro Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Nipro Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nipro Recent Developments
11.3 MEDIVATORS
11.3.1 MEDIVATORS Corporation Information
11.3.2 MEDIVATORS Overview
11.3.3 MEDIVATORS Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 MEDIVATORS Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MEDIVATORS Recent Developments
11.4 Dialysis Medical Solutions
11.4.1 Dialysis Medical Solutions Corporation Information
11.4.2 Dialysis Medical Solutions Overview
11.4.3 Dialysis Medical Solutions Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dialysis Medical Solutions Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dialysis Medical Solutions Recent Developments
11.5 Fresenius Medical Care
11.5.1 Fresenius Medical Care Corporation Information
11.5.2 Fresenius Medical Care Overview
11.5.3 Fresenius Medical Care Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Fresenius Medical Care Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fresenius Medical Care Recent Developments
11.6 Baxter
11.6.1 Baxter Corporation Information
11.6.2 Baxter Overview
11.6.3 Baxter Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Baxter Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Baxter Recent Developments
11.7 B. Braun
11.7.1 B. Braun Corporation Information
11.7.2 B. Braun Overview
11.7.3 B. Braun Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 B. Braun Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 B. Braun Recent Developments
11.8 Renacon Pharma
11.8.1 Renacon Pharma Corporation Information
11.8.2 Renacon Pharma Overview
11.8.3 Renacon Pharma Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Renacon Pharma Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Renacon Pharma Recent Developments
11.9 Surni Group
11.9.1 Surni Group Corporation Information
11.9.2 Surni Group Overview
11.9.3 Surni Group Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Surni Group Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Surni Group Recent Developments
11.10 Weigao Group
11.10.1 Weigao Group Corporation Information
11.10.2 Weigao Group Overview
11.10.3 Weigao Group Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Weigao Group Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Weigao Group Recent Developments
11.11 BIOLIGHT
11.11.1 BIOLIGHT Corporation Information
11.11.2 BIOLIGHT Overview
11.11.3 BIOLIGHT Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 BIOLIGHT Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BIOLIGHT Recent Developments
11.12 Taishikang
11.12.1 Taishikang Corporation Information
11.12.2 Taishikang Overview
11.12.3 Taishikang Haemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Taishikang Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Taishikang Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Haemodialysis Concentrates Industry Chain Analysis
12.2 Haemodialysis Concentrates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Haemodialysis Concentrates Production Mode & Process
12.4 Haemodialysis Concentrates Sales and Marketing
12.4.1 Haemodialysis Concentrates Sales Channels
12.4.2 Haemodialysis Concentrates Distributors
12.5 Haemodialysis Concentrates Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Haemodialysis Concentrates Industry Trends
13.2 Haemodialysis Concentrates Market Drivers
13.3 Haemodialysis Concentrates Market Challenges
13.4 Haemodialysis Concentrates Market Restraints
14 Key Findings in The Global Haemodialysis Concentrates Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Haemodialysis Concentrates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Bicarbonate Concentrates
Table 3. Major Manufacturers of Acid Concentrates
Table 4. Global Haemodialysis Concentrates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Haemodialysis Concentrates Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Haemodialysis Concentrates Sales by Region (2017-2022) & (K Units)
Table 7. Global Haemodialysis Concentrates Sales Market Share by Region (2017-2022)
Table 8. Global Haemodialysis Concentrates Sales by Region (2023-2028) & (K Units)
Table 9. Global Haemodialysis Concentrates Sales Market Share by Region (2023-2028)
Table 10. Global Haemodialysis Concentrates Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Haemodialysis Concentrates Revenue Market Share by Region (2017-2022)
Table 12. Global Haemodialysis Concentrates Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Haemodialysis Concentrates Revenue Market Share by Region (2023-2028)
Table 14. Global Haemodialysis Concentrates Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Haemodialysis Concentrates Sales Share by Manufacturers (2017-2022)
Table 16. Global Haemodialysis Concentrates Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Haemodialysis Concentrates Revenue Share by Manufacturers (2017-2022)
Table 18. Haemodialysis Concentrates Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Haemodialysis Concentrates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Haemodialysis Concentrates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemodialysis Concentrates as of 2021)
Table 21. Haemodialysis Concentrates Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Haemodialysis Concentrates Product Offered
Table 23. Date of Manufacturers Enter into Haemodialysis Concentrates Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Haemodialysis Concentrates Sales by Type (2017-2022) & (K Units)
Table 26. Global Haemodialysis Concentrates Sales by Type (2023-2028) & (K Units)
Table 27. Global Haemodialysis Concentrates Sales Share by Type (2017-2022)
Table 28. Global Haemodialysis Concentrates Sales Share by Type (2023-2028)
Table 29. Global Haemodialysis Concentrates Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Haemodialysis Concentrates Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Haemodialysis Concentrates Revenue Share by Type (2017-2022)
Table 32. Global Haemodialysis Concentrates Revenue Share by Type (2023-2028)
Table 33. Haemodialysis Concentrates Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Haemodialysis Concentrates Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Haemodialysis Concentrates Sales by Application (2017-2022) & (K Units)
Table 36. Global Haemodialysis Concentrates Sales by Application (2023-2028) & (K Units)
Table 37. Global Haemodialysis Concentrates Sales Share by Application (2017-2022)
Table 38. Global Haemodialysis Concentrates Sales Share by Application (2023-2028)
Table 39. Global Haemodialysis Concentrates Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Haemodialysis Concentrates Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Haemodialysis Concentrates Revenue Share by Application (2017-2022)
Table 42. Global Haemodialysis Concentrates Revenue Share by Application (2023-2028)
Table 43. Haemodialysis Concentrates Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Haemodialysis Concentrates Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Haemodialysis Concentrates Sales by Type (2017-2022) & (K Units)
Table 46. North America Haemodialysis Concentrates Sales by Type (2023-2028) & (K Units)
Table 47. North America Haemodialysis Concentrates Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Haemodialysis Concentrates Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Haemodialysis Concentrates Sales by Application (2017-2022) & (K Units)
Table 50. North America Haemodialysis Concentrates Sales by Application (2023-2028) & (K Units)
Table 51. North America Haemodialysis Concentrates Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Haemodialysis Concentrates Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Haemodialysis Concentrates Sales by Country (2017-2022) & (K Units)
Table 54. North America Haemodialysis Concentrates Sales by Country (2023-2028) & (K Units)
Table 55. North America Haemodialysis Concentrates Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Haemodialysis Concentrates Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Haemodialysis Concentrates Sales by Type (2017-2022) & (K Units)
Table 58. Europe Haemodialysis Concentrates Sales by Type (2023-2028) & (K Units)
Table 59. Europe Haemodialysis Concentrates Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Haemodialysis Concentrates Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Haemodialysis Concentrates Sales by Application (2017-2022) & (K Units)
Table 62. Europe Haemodialysis Concentrates Sales by Application (2023-2028) & (K Units)
Table 63. Europe Haemodialysis Concentrates Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Haemodialysis Concentrates Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Haemodialysis Concentrates Sales by Country (2017-2022) & (K Units)
Table 66. Europe Haemodialysis Concentrates Sales by Country (2023-2028) & (K Units)
Table 67. Europe Haemodialysis Concentrates Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Haemodialysis Concentrates Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Haemodialysis Concentrates Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Haemodialysis Concentrates Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Haemodialysis Concentrates Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Haemodialysis Concentrates Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Haemodialysis Concentrates Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Haemodialysis Concentrates Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Haemodialysis Concentrates Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Haemodialysis Concentrates Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Haemodialysis Concentrates Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Haemodialysis Concentrates Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Haemodialysis Concentrates Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Haemodialysis Concentrates Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Haemodialysis Concentrates Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Haemodialysis Concentrates Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Haemodialysis Concentrates Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Haemodialysis Concentrates Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Haemodialysis Concentrates Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Haemodialysis Concentrates Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Haemodialysis Concentrates Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Haemodialysis Concentrates Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Haemodialysis Concentrates Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Haemodialysis Concentrates Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Haemodialysis Concentrates Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Haemodialysis Concentrates Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Haemodialysis Concentrates Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Haemodialysis Concentrates Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Haemodialysis Concentrates Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Haemodialysis Concentrates Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Haemodialysis Concentrates Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Haemodialysis Concentrates Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Haemodialysis Concentrates Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Haemodialysis Concentrates Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Haemodialysis Concentrates Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Haemodialysis Concentrates Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Haemodialysis Concentrates Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Haemodialysis Concentrates Revenue by Country (2023-2028) & (US$ Million)
Table 105. Rockwell Medical Corporation Information
Table 106. Rockwell Medical Description and Major Businesses
Table 107. Rockwell Medical Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Rockwell Medical Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Rockwell Medical Recent Developments
Table 110. Nipro Corporation Information
Table 111. Nipro Description and Major Businesses
Table 112. Nipro Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Nipro Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Nipro Recent Developments
Table 115. MEDIVATORS Corporation Information
Table 116. MEDIVATORS Description and Major Businesses
Table 117. MEDIVATORS Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. MEDIVATORS Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. MEDIVATORS Recent Developments
Table 120. Dialysis Medical Solutions Corporation Information
Table 121. Dialysis Medical Solutions Description and Major Businesses
Table 122. Dialysis Medical Solutions Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Dialysis Medical Solutions Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Dialysis Medical Solutions Recent Developments
Table 125. Fresenius Medical Care Corporation Information
Table 126. Fresenius Medical Care Description and Major Businesses
Table 127. Fresenius Medical Care Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Fresenius Medical Care Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Fresenius Medical Care Recent Developments
Table 130. Baxter Corporation Information
Table 131. Baxter Description and Major Businesses
Table 132. Baxter Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Baxter Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Baxter Recent Developments
Table 135. B. Braun Corporation Information
Table 136. B. Braun Description and Major Businesses
Table 137. B. Braun Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. B. Braun Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. B. Braun Recent Developments
Table 140. Renacon Pharma Corporation Information
Table 141. Renacon Pharma Description and Major Businesses
Table 142. Renacon Pharma Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Renacon Pharma Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Renacon Pharma Recent Developments
Table 145. Surni Group Corporation Information
Table 146. Surni Group Description and Major Businesses
Table 147. Surni Group Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Surni Group Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Surni Group Recent Developments
Table 150. Weigao Group Corporation Information
Table 151. Weigao Group Description and Major Businesses
Table 152. Weigao Group Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Weigao Group Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Weigao Group Recent Developments
Table 155. BIOLIGHT Corporation Information
Table 156. BIOLIGHT Description and Major Businesses
Table 157. BIOLIGHT Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. BIOLIGHT Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. BIOLIGHT Recent Developments
Table 160. Taishikang Corporation Information
Table 161. Taishikang Description and Major Businesses
Table 162. Taishikang Haemodialysis Concentrates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Taishikang Haemodialysis Concentrates Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Taishikang Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Haemodialysis Concentrates Distributors List
Table 168. Haemodialysis Concentrates Customers List
Table 169. Haemodialysis Concentrates Market Trends
Table 170. Haemodialysis Concentrates Market Drivers
Table 171. Haemodialysis Concentrates Market Challenges
Table 172. Haemodialysis Concentrates Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Haemodialysis Concentrates Product Picture
Figure 3. Global Haemodialysis Concentrates Market Share by Type in 2021 & 2028
Figure 3. Bicarbonate Concentrates Product Picture
Figure 4. Acid Concentrates Product Picture
Figure 5. Global Haemodialysis Concentrates Market Share by Application in 2021 & 2028
Figure 6. Dialysis Center
Figure 7. Home Dialysis
Figure 8. Others
Figure 9. Haemodialysis Concentrates Report Years Considered
Figure 10. Global Haemodialysis Concentrates Sales 2017-2028 (K Units)
Figure 11. Global Haemodialysis Concentrates Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Haemodialysis Concentrates Revenue 2017-2028 (US$ Million)
Figure 13. Global Haemodialysis Concentrates Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Haemodialysis Concentrates Sales Market Share by Region (2017-2022)
Figure 15. Global Haemodialysis Concentrates Sales Market Share by Region (2023-2028)
Figure 16. North America Haemodialysis Concentrates Sales YoY (2017-2028) & (K Units)
Figure 17. North America Haemodialysis Concentrates Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Haemodialysis Concentrates Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Haemodialysis Concentrates Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Haemodialysis Concentrates Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Haemodialysis Concentrates Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Haemodialysis Concentrates Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Haemodialysis Concentrates Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Haemodialysis Concentrates Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Haemodialysis Concentrates Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Haemodialysis Concentrates Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Haemodialysis Concentrates in the World: Market Share by Haemodialysis Concentrates Revenue in 2021
Figure 28. Global Haemodialysis Concentrates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Haemodialysis Concentrates Sales Market Share by Type (2017-2028)
Figure 30. Global Haemodialysis Concentrates Revenue Market Share by Type (2017-2028)
Figure 31. Global Haemodialysis Concentrates Sales Market Share by Application (2017-2028)
Figure 32. Global Haemodialysis Concentrates Revenue Market Share by Application (2017-2028)
Figure 33. North America Haemodialysis Concentrates Sales Market Share by Type (2017-2028)
Figure 34. North America Haemodialysis Concentrates Revenue Market Share by Type (2017-2028)
Figure 35. North America Haemodialysis Concentrates Sales Market Share by Application (2017-2028)
Figure 36. North America Haemodialysis Concentrates Revenue Market Share by Application (2017-2028)
Figure 37. North America Haemodialysis Concentrates Sales Share by Country (2017-2028)
Figure 38. North America Haemodialysis Concentrates Revenue Share by Country (2017-2028)
Figure 39. United States Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Haemodialysis Concentrates Sales Market Share by Type (2017-2028)
Figure 42. Europe Haemodialysis Concentrates Revenue Market Share by Type (2017-2028)
Figure 43. Europe Haemodialysis Concentrates Sales Market Share by Application (2017-2028)
Figure 44. Europe Haemodialysis Concentrates Revenue Market Share by Application (2017-2028)
Figure 45. Europe Haemodialysis Concentrates Sales Share by Country (2017-2028)
Figure 46. Europe Haemodialysis Concentrates Revenue Share by Country (2017-2028)
Figure 47. Germany Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 48. France Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Haemodialysis Concentrates Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Haemodialysis Concentrates Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Haemodialysis Concentrates Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Haemodialysis Concentrates Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Haemodialysis Concentrates Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Haemodialysis Concentrates Revenue Share by Region (2017-2028)
Figure 58. China Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 61. India Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Haemodialysis Concentrates Sales Market Share by Type (2017-2028)
Figure 68. Latin America Haemodialysis Concentrates Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Haemodialysis Concentrates Sales Market Share by Application (2017-2028)
Figure 70. Latin America Haemodialysis Concentrates Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Haemodialysis Concentrates Sales Share by Country (2017-2028)
Figure 72. Latin America Haemodialysis Concentrates Revenue Share by Country (2017-2028)
Figure 73. Mexico Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Haemodialysis Concentrates Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Haemodialysis Concentrates Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Haemodialysis Concentrates Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Haemodialysis Concentrates Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Haemodialysis Concentrates Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Haemodialysis Concentrates Revenue Share by Country (2017-2028)
Figure 83. Turkey Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Haemodialysis Concentrates Revenue (2017-2028) & (US$ Million)
Figure 86. Haemodialysis Concentrates Value Chain
Figure 87. Haemodialysis Concentrates Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed